Maximon
Venture studioZug · Pre-Seed–Series A · 23 people tracked
Investment thesis
Maximon operates as a company builder centered on the longevity space, empowering entrepreneurs to launch impactful, science-based and scalable ventures. Its focus is on healthy aging and rejuvenation solutions grounded in scientific research.
Source: firm website, verified Jul 31, 2026.
Team · 23 people
from the firm's websiteCaroline Wagner has extensive experience in digital business building and innovation. She was among the first employees and part of the management team at SumUp, and later led cross-functional teams in venture building as a Lead Venture Architect at BCG Digital Ventures in Berlin.
Adrian Locher is co-founder and CEO of Merantix, a Berlin-based venture studio focused on AI. Over roughly 20 years he has worked as an entrepreneur and investor, founding more than 10 companies in Europe and the US across AI, digital healthcare, and e-commerce, including a Swiss e-commerce firm he sold at EUR 100M in revenue. He holds a degree in business and economics from the University of St. Gallen (HSG).
Dalma Riczu holds a Master's degree in Work and Organizational Psychology and has more than five years of Human Resources experience across corporate and agency settings. She has built and managed talent advisory teams focused on the pharmaceutical, biotech, and MedTech industries. Her areas of interest include mental well-being, longevity, and organizational development.
Co-founder and Chief Medical Officer at Frieda Health, a Maximon portfolio company.
Duri Granziol has a background in direct-to-consumer and e-commerce, having co-founded and led Mama's Choice, a D2C brand for mothers and babies in Southeast Asia, and previously serving as Co-CEO of what was then Indonesia's largest e-commerce marketplace. Through consulting work in health insurance and a personal health experience, he developed an interest in preventive health and longevity, and now works in that field as Co-Founder and CEO of Avea.
Lucia Kupcova is an event manager with over 8 years of experience in event and project management across sectors including real estate and international education. She has organized more than 50 B2B and B2G conferences internationally.
Nina Ruge began a television career in 1987 with RIAS TV in Berlin, later appearing on ZDF programs such as "heute journal", "heute Nacht", and "Leute heute", and hosting various talk shows and TV magazines. Since 2021 she has authored several German-language books on cell biology of aging and healthy longevity, all of which reached the SPIEGEL bestseller list. She works primarily as an author focused on the cell biology of aging, gives lectures on healthy longevity, and communicates on the topic through media and social channels.
Pascal Rode is Co-Founder and COO at AVEA. His entrepreneurial background spans fintech and foodtech, where he co-founded and built several companies before moving into longevity and healthtech. Earlier in his career he held senior management roles at large financial corporations, focused on delivering value through technology.
Simona Eicher works as a Lead Venture Builder at Maximon, focusing on business building and innovation. Before joining the firm, she was at McKinsey & Company, where she led cross-functional teams and helped clients launch new products and implement digital solutions. She holds an MBA from Said Business School at the University of Oxford and a Master's in Management and Economics from the University of Zurich.
Sophie Chabloz holds an MSc in Food Science, Nutrition & Health from ETH Zürich, where her research examined potential anti-aging molecules in human cells. She has experience in product innovation, development, and commercialization, including work at a large FMCG company and a prior startup. She focuses on functional ingredients and health and wellbeing products.
Teresa Budetta is Co-Founder and CMO at AVEA. She holds a BSc in Finance from Bocconi University and an MSc in International Business from Esade Business School, and began her career in investment banking before moving into marketing. She previously worked at H-Farm Digital Marketing Agency and Mondadori, held content and brand roles at the health company Lykon and at Foodspring, and in 2020 started a consulting agency supporting funded startups with internationalization.
Thanh Schrader-Nguyen has around 10 years of experience in venture building and digital product design and management, with over 5 years in medtech, including German DiGAs where she launched three mental health applications. She has worked at IBM, BCG Digital Ventures, and Selfapy, and previously founded cyclio, a corporate menstrual health benefit company. She is Co-Founder and CPTO of Frieda Health.
Founder and CEO of Frieda Health, a Maximon portfolio company.
Frequently asked questions
- What stage does Maximon invest at?
- Maximon invests at the Pre-Seed, Seed, Series A stages.
- What is Maximon's typical check size?
- Maximon typically writes checks of $11M.
- What sectors does Maximon focus on?
- Maximon focuses on Biotech, Healthtech, Longevity, Wellness & Fitness.
- Where is Maximon located?
- Maximon is headquartered in Zug, CH.
Media · Podcasts & interviews
featuring the teamMarc P. Bernegger - Founder Maximon: Longevity & Bitcoin (#PE20) - YouTube
Mannheim Investment Club e.V. · Marc P. Bernegger
Images
Similar investors
Better Ventures is a venture capital firm that backs early-stage, mission-driven technology companies building a better world. It invests across climate, health, and future-of-work themes using AI, software, biology, and materials science.
Obvious is a venture capital firm focused on supporting founders building solutions to humanity's largest challenges across planetary health, human health, and economic health.
Seed Healthcare invests in and advises healthcare startups focused on early disease detection and prevention, providing capital, technology implementation, and advisory services across investment, sales growth, and provider strategy.
Embryo Ventures is an early-stage venture firm backing founders building technologies that advance human health and reshape everyday human experience.
Exceptional Ventures is a London-based venture capital firm investing in early-stage companies focused on helping people live longer, healthier, and happier lives across wellness, risk assessment and early detection, and treatment and care delivery.






















